LONDON, June 29 (Reuters) – The world’s first malaria
vaccine, developed by GlaxoSmithKline, provides some
protection after three doses but its effect dwindles to almost
nothing after seven years,…
The post Limited protection of GSK’s malaria vaccine dwindles in 7 years appeared first on NASDAQ.